Graymark Healthcare Inc  

(Public, NASDAQ:GRMH)   Watch this stock  
Find more results for GRMH
0.330
0.000 (0.00%)
Real-time:   12:28PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 0.28 - 1.30
Open     -
Vol / Avg. 0.00/3,541.00
Mkt cap 4.97M
P/E     -
Div/yield     -
EPS -0.48
Shares 15.07M
Beta 0.45
Inst. own 41%
May 15, 2012
Q1 2012 Graymark Healthcare, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin -44.52% -36.65%
Operating margin -37.81% -29.25%
EBITD margin - -22.90%
Return on average assets -29.01% -22.65%
Return on average equity -189.58% -234.64%
Employees 186 -
Carbon Disclosure Rating - -

Address

Ste. 400, 204 N. Robinson Avenue
OKLAHOMA CITY, OK 73102
United States - Map
+1-405-6015300 (Phone)
+1-405-6014550 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Graymark Healthcare, Inc. is the provider of care management solutions to the sleep disorder market based on number of independent sleep care centers and hospital sleep diagnostic programs operated in the United States. The Company provides diagnosis and care management solution for patients suffering from sleep disorders. It provides diagnostic sleep testing services and care management solutions, or Sleep Management Solutions (SMS), for people with chronic sleep disorders. In addition, it provides therapy services, delivery and set up of continuous positive airway pressure (CPAP) equipment together with training related to the operation and maintenance of CPAP equipment, and the sale of related disposable supplies and components used to maintain the CPAP equipment. In May 2011, it sold Nocturna East Sleep Centers unit. In April 2012, it opened four new facilities for its comprehensive sleep medicine services.

Officers and directors

Jamie E. Hopping Independent Chairman of the Board
Age: 58
Bio & Compensation - Reuters
Stanton Nelson Chief Executive Officer, Director
Age: 41
Bio & Compensation - Reuters
Mark R. Kidd Interim Chief Financial Officer
Age: 45
Bio & Compensation - Reuters
Grant A. Christianson Chief Accounting Officer, Treasurer
Age: 42
Bio & Compensation - Reuters
Joseph Harroz Jr. Director
Age: 45
Bio & Compensation - Reuters
S. Edward Dakil M.D. Independent Director
Age: 56
Bio & Compensation - Reuters
Steven L. List Independent Director
Age: 44
Bio & Compensation - Reuters
Scott R. Mueller Independent Director
Age: 41
Bio & Compensation - Reuters